These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5035966)

  • 41. A rapid method for the detection of bacterial contaminants in intravenous fluids using membrane filtration and epifluorescence microscopy.
    Denyer SP; Ward KH
    J Parenter Sci Technol; 1983; 37(5):156-8. PubMed ID: 6655531
    [No Abstract]   [Full Text] [Related]  

  • 42. Intravenous infusion motor artifact.
    Lininger AW; Volow MR; Gianturco DT
    Am J EEG Technol; 1981 Dec; 21(4):167-73. PubMed ID: 10254009
    [No Abstract]   [Full Text] [Related]  

  • 43. Unit-of-use versus traditional intravenous piggyback drug administration systems.
    Tribble DA; Fotis M; McDonald DE
    Am J Hosp Pharm; 1979 Jun; 36(6):739, 742. PubMed ID: 111545
    [No Abstract]   [Full Text] [Related]  

  • 44. A study of particulate matter in I.V. infusion fluids.
    Davis NM; Turco S; Sivelly E
    Am J Hosp Pharm; 1970 Oct; 27(10):822-6. PubMed ID: 5473472
    [No Abstract]   [Full Text] [Related]  

  • 45. Continuous intravenous administration of drugs.
    Paris P; Hans P; Lamy M
    Acta Anaesthesiol Belg; 1983 Jun; 34(2):109-15. PubMed ID: 6613510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Insoluble contaminants in large-volume parenteral infusion fluids. Use of the particle counter LZ-2].
    Pawlaczyk J; Nowacka D
    Acta Pol Pharm; 1981; 38(4):473-8. PubMed ID: 7331835
    [No Abstract]   [Full Text] [Related]  

  • 47. Review of the justification for pharmacy parenteral admixture preparation.
    Schneider PJ
    Hosp Pharm; 1981 Sep; 16(9):476, 478-9, 484. PubMed ID: 10252377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Syringes versus minibags as an intravenous admixture system: a comparison of cost and nursing preference.
    Gin A; Martens D; Dobson K; Hall K
    Can J Hosp Pharm; 1987 Jun; 40(3):81-5. PubMed ID: 10282581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Portable chemotherapy pumps in pediatric oncology: psychosocial and cost considerations.
    Pryor A
    J Assoc Pediatr Oncol Nurses; 1984; 1(4):14. PubMed ID: 6570488
    [No Abstract]   [Full Text] [Related]  

  • 50. Problems with intravenous solutions.
    Gladhart WR; Simpson TR
    Am J Hosp Pharm; 1972 Nov; 29(11):918. PubMed ID: 4654997
    [No Abstract]   [Full Text] [Related]  

  • 51. Final inline filters.
    Millam DA
    Am J Nurs; 1979 Jul; 79(7):1272-3. PubMed ID: 256449
    [No Abstract]   [Full Text] [Related]  

  • 52. Addition of drugs to intravenous fluids.
    Engel G
    Med J Aust; 1971 Nov; 2(19):962-6. PubMed ID: 5117309
    [No Abstract]   [Full Text] [Related]  

  • 53. Solutions in plastic or glass: do the savings matter?
    Holzman M
    Hosp Purch Manage; 1982 Sep; 7(9):8-9. PubMed ID: 10309716
    [No Abstract]   [Full Text] [Related]  

  • 54. Big discounts mask high profits in solutions market dominated by Travenol and Abbott.
    Hosp Purch Manage; 1978 Oct; 3(10):3-9. PubMed ID: 10238751
    [No Abstract]   [Full Text] [Related]  

  • 55. [An apparatus for the filtration of fluids for intravenous infusion].
    VAN STEENBERGEN HA
    Pharm Weekbl; 1955 Mar; 90(6):177-81. PubMed ID: 14370914
    [No Abstract]   [Full Text] [Related]  

  • 56. Nitroglycerin compatibility with intravenous fluid filters, containers, and administration sets.
    Baaske DM; Amann AH; Wagenknecht DM; Mooers M; Carter JE; Hoyt HJ; Stoll RG
    Am J Hosp Pharm; 1980 Feb; 37(2):201-5. PubMed ID: 6767400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compatibility and stability of clindamycin phosphate with intravenous fluids.
    Porter WR; Johnson CA; Cohon MS; Gillespie W
    Am J Hosp Pharm; 1983 Jan; 40(1):91-4. PubMed ID: 6823996
    [No Abstract]   [Full Text] [Related]  

  • 58. Interactions between drugs and intravenous delivery systems.
    Kowaluk EA; Roberts MS; Polack AE
    Am J Hosp Pharm; 1982 Mar; 39(3):460-7. PubMed ID: 7072732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential toxicity from nickel contamination of intravenous fluids.
    Sunderman FW
    Ann Clin Lab Sci; 1983; 13(1):1-4. PubMed ID: 6340593
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of drop sizes of intravenous administration sets.
    Merrick IM; Merrick TE
    Am J Hosp Pharm; 1980 Oct; 37(10):1346-50. PubMed ID: 7424932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.